Skip to Content
 
Center for International Blood and Marrow Transplant Research

LY22-02d

Main Content

Efficacy and safety of CD19 directed CAR T-cell therapy for Richter's transformation.

Study #: LY22-02d

Study Status: Published

Presentation(s)

2025, Tandem (Poster)

Chimeric antigen receptor T-cell therapy for richter transformation: A CIBMTR analysis.

Citation

Nadiminti KV, Ahn KW, Patel J, Lian Q, Bezerra E, Chen A, Ganguly S, Gergis U, Hashmi H, Kharfan-Dabaja MA, Kuruvilla J, Lekakis L, Locke FL, Murthy H, Mousthafa MA, Perales MA, Pophali P, Riedell PA, Shah NN, Wang T, Pasquini M, Hamadani M, Turtle CJ, Herrera AF, Shadman M.

Transplantation and Cellular Therapy. 2025, Aug 01: S2666-6367(25): S2666-6367(25):01334-X. doi: 10.1016/j.jtct.2025.07.02. Epub 2025, Aug 01. PMCID:.

PubMed

PMID: 40754223

Abstract